Abstract
Importance Trauma causes over four million deaths annually, predominantly in low- and middle-income countries. Implementing trauma quality improvement programs may improve outcomes, and though extensively used, high-quality evidence of their effectiveness is scarce.
Objective To assess if implementing a trauma quality improvement program using on audit filters improves trauma patients’ outcomes.
Design A controlled interrupted time-series study.
Setting Prospective, multicenter study across four tertiary care hospitals in urban India between 2017-2022.
Participants Adult patients admitted to participating hospitals with history a of trauma, defined as having any of the external causes listed in block V01-Y36, chapter XX of the ICD-10 as reason for admission.
Intervention In the intervention arm (two hospitals), a trauma quality improvement program using audit filters was implemented after a one-year observation period. The control arm (two hospitals) continued baseline data collection without intervention throughout the study period.
Main Outcomes All-cause mortality (in-hospital and at 30 days). For time series analysis, segmented regression with a generalized additive model (GAM) assessed the effect on in-hospital mortality. Secondary analysis using difference-in-differences and linear regression assessed in-hospital and 30-day mortality. The study was not powered for time series analysis on 30-day mortality.
Results We included 10143 patients, median age 35 (IQR 26 – 50), 83% men. Using time series analysis, we observed a significant reduction in in-hospital mortality (32% vs 24%; OR 0.56, 95% CI 0.4-0.77, p<0.001) in the intervention arm, with no significant change in the control arm. Difference-in-differences analysis found a significant reduction in 30-day mortality (39% vs 26%; DiD estimate -0.15 95% CI -0.19 to -0.11, p<0.001) and in-hospital mortality (32% vs 24%; DiD estimate -0.12 95% CI -0.16 to -0.09, p<0.001). However, external factors such as the opening of a dedicated trauma center at one intervention hospital and the COVID-19 pandemic may have influenced these results.
Conclusion Implementing a trauma quality improvement program using audit filters may reduce mortality. More research is needed to confirm these findings across different settings and to understand by which mechanisms these programs mediate the effect and ensure sustainability in terms of improving outcomes.
Trial registration Trauma Audit Filter Trial, ClinicalTrials.gov ID NCT03235388, https://clinicaltrials.gov/study/NCT03235388
Question Does implementing a trauma quality improvement program using audit filters improve mortality in adult trauma patients?
Findings In this prospective, multicentre, controlled interrupted time series including 10143 patients across four tertiary care hospitals in urban India, we observed a significant reduction in all-cause 30-day and in-hospital mortality after implementing a trauma quality improvement program using audit filters.
Meaning implementing trauma quality improvement programs using audit filters may reduce mortality. However, these programs require local adaptation, and their effectiveness is dependent on the setting, context and maturity of the health care system.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03235388
Funding Statement
This work was supported by the Swedish Research Council (2016-02041)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consent to take part of the intervention was not deemed applicable, as it was a hospital level intervention. We were granted waivers of informed consent for recording vital signs, demographic parameters and in-hospital outcomes. We obtained written consent for telephonic follow-up. Ethical approvals were granted by the Swedish Ethical Review Authority, approved 2017-06-07 2017/930-31/2, as well as at all local ethical review boards for each participating hospital: Maulana Azad Medical College, MAMC - approved 2017-07-19 F.1/IEC/MAMC/(57/02/2017/No113. SSKM/IPGME&R, Kolkata - approved 2017-08-21, IPGME&R/IEC/2017/396. JJ Hospital, Mumbai - approved 2017-08-22, No.IEC/Pharm/CT/111/A/2017. St Johns, Bangalore - approved 2017-08-24, 160/2017.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This version has been revised: Language revision Minor analysis update to correct status for status at 24 hours and in hospital mortality Addition of study flowchart Updated supplementary material Updated figure 1
Data Availability
All data in the present study consists of sensitive patient information. To protect the privacy of the participants, this data cannot be released outside the scope of this research collaboration in its current form. We are in the process of creating an anonymised version of this data, which we aim to release openly. This anonymized dataset will be published alongside a data descriptor paper to facilitate open-access use.
